Long-term study shows knee replacements last lifetime for active young adults

A 40-year study by Hospital for Special Surgery (HSS) researchers has found that active young adults who underwent total knee replacement were unlikely to require knee replacement revision in their lifetime, according to a new study shared today in a podium presentation at the American Academy of Orthopaedic Surgeons 2025 Annual Meeting.

VA Can Be a Leader in Healthcare AI, Lawmakers Say

The Department of Veterans Affairs (VA) must balance innovation with careful implementation of emerging artificial intelligence (AI) technology, lawmakers and witnesses said during a House

February 16, 2024

Axi-Cel Shows Durable Responses, Prolongs Overall Survival in Older LBCL Patients

Durable responses were seen when axicabtagene ciloleucel (axi-cel; Yescarta) was administered as a first-line therapy for patients with high-risk large B-cell lymphoma (LBCL), according to

January 5, 2024

Allogeneic Stem Cell Therapy Falls Short on Stroke Outcomes

Bone marrow-derived allogeneic stem cell therapy shortly after ischemic stroke did not improve outcomes at 90 days, a phase II/III randomized clinical trial known as

January 18, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.